Objective: To assess the frequency of warfarin use, the achieved international normalised ratio (INR) balance among warfarin users and the primary healthcare outpatient costs of patients with atrial fibrillation (AF).
Design: Retrospective, non-interventional registry study.
Setting: Primary healthcare.